BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20491781)

  • 1. Hypoxia promotes metastasis in human gastric cancer by up-regulating the 67-kDa laminin receptor.
    Liu L; Sun L; Zhao P; Yao L; Jin H; Liang S; Wang Y; Zhang D; Pang Y; Shi Y; Chai N; Zhang H; Zhang H
    Cancer Sci; 2010 Jul; 101(7):1653-60. PubMed ID: 20491781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-1α and HIF-2α correlate with migration and invasion in gastric cancer.
    Wang Y; Li Z; Zhang H; Jin H; Sun L; Dong H; Xu M; Zhao P; Zhang B; Wang J; Pan Y; Liu L
    Cancer Biol Ther; 2010 Aug; 10(4):376-82. PubMed ID: 20559021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer.
    Jin H; Pan Y; He L; Zhai H; Li X; Zhao L; Sun L; Liu J; Hong L; Song J; Xie H; Gao J; Han S; Li Y; Fan D
    Mol Cancer Res; 2007 May; 5(5):423-33. PubMed ID: 17510309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells.
    Li Y; Tan BB; Zhao Q; Fan LQ; Wang D; Liu Y
    Neoplasma; 2014; 61(3):291-8. PubMed ID: 24824930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 67-kDa laminin receptor in human bile duct carcinoma.
    Li D; Chen J; Gao Z; Li X; Yan X; Xiong Y; Wang S
    Eur Surg Res; 2009; 42(3):168-73. PubMed ID: 19182490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERK/MAPK activation involves hypoxia-induced MGr1-Ag/37LRP expression and contributes to apoptosis resistance in gastric cancer.
    Liu L; Zhang H; Sun L; Gao Y; Jin H; Liang S; Wang Y; Dong M; Shi Y; Li Z; Fan D
    Int J Cancer; 2010 Aug; 127(4):820-9. PubMed ID: 19998339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-thermal atmospheric pressure plasma inhibits thyroid papillary cancer cell invasion via cytoskeletal modulation, altered MMP-2/-9/uPA activity.
    Chang JW; Kang SU; Shin YS; Kim KI; Seo SJ; Yang SS; Lee JS; Moon E; Lee K; Kim CH
    PLoS One; 2014; 9(3):e92198. PubMed ID: 24667444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment.
    Lee KH; Choi EY; Koh SA; Kim MK; Jang BI; Kim SW; Kim JR
    Oncol Rep; 2014 May; 31(5):2123-30. PubMed ID: 24626561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance in gene expression of matrix metalloproteinase-9, urokinase-type plasminogen activator and tissue inhibitor of metalloproteinase for metastases of gastric and/or colo-rectal cancer].
    Koumura H; Sugiyama Y; Kunieda K; Saji S
    Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():324-31. PubMed ID: 9263524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer.
    Pesapane A; Ragno P; Selleri C; Montuori N
    Curr Pharm Des; 2017; 23(32):4745-4757. PubMed ID: 28699539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia Promotes Extravillous Trophoblast Cell Invasion through the Hypoxia-Inducible Factor Urokinase-Type Plasminogen Activator Receptor Pathway.
    Shigemitsu A; Naruse K; Kobayashi H
    Gynecol Obstet Invest; 2022; 87(3-4):232-241. PubMed ID: 35785760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.
    Berno V; Porrini D; Castiglioni F; Campiglio M; Casalini P; Pupa SM; Balsari A; Ménard S; Tagliabue E
    Endocr Relat Cancer; 2005 Jun; 12(2):393-406. PubMed ID: 15947111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression.
    Khan KM; Falcone DJ
    J Biol Chem; 1997 Mar; 272(13):8270-5. PubMed ID: 9079647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between matrix metalloproteinase-2 mRNA expression and clinicopathological and urokinase-type plasminogen activator system parameters and prognosis in human gastric cancer.
    Ji F; Chen YL; Jin EY; Wang WL; Yang ZL; Li YM
    World J Gastroenterol; 2005 Jun; 11(21):3222-6. PubMed ID: 15929171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9.
    Zhang BG; Du T; Zang MD; Chang Q; Fan ZY; Li JF; Yu BQ; Su LP; Li C; Yan C; Gu QL; Zhu ZG; Yan M; Liu B
    Oncotarget; 2014 Nov; 5(21):10584-95. PubMed ID: 25301736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9.
    Peng TL; Chen J; Mao W; Song X; Chen MH
    BMC Cell Biol; 2009 Apr; 10():27. PubMed ID: 19371443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 67-kDa laminin receptor in human laryngeal squamous cell carcinoma.
    Zhou L; Xie M; Zhou JQ; Tao L
    Laryngoscope; 2006 Jan; 116(1):28-32. PubMed ID: 16481804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis.
    Thummarati P; Wijitburaphat S; Prasopthum A; Menakongka A; Sripa B; Tohtong R; Suthiphongchai T
    World J Gastroenterol; 2012 Jan; 18(3):244-50. PubMed ID: 22294827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.